•Potassium do Brasil, a subsidiary of Brazil Potash, formalized a Term of Commitment and Cooperation with the Mura Indigenous Council (CIM).
•The agreement aims for sustainable territorial development and improving living conditions in indigenous communities in the Autazes municipality, Amazonas.
•This step supports the Autazes Potash Project being developed by the company in the Amazon region.
•China's National Medical Products Administration (NMPA) approved TP-03 (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis.
•The regulatory approval triggers a $15 million milestone payment due to Tarsus Pharmaceuticals.
•The drug is marketed in the United States under the brand name XDEMVY.
•YZi Labs highlighted a systemic governance breakdown at CEA Industries and condemned a $2 million 'golden parachute' for outgoing CEO David Namdar.
•Recent filings disclosed material weaknesses in internal controls, including a lack of segregation of duties between the CEO and accounting functions.